Novavax Inc Strategic Asset Allocation Index
Novavax Inc strategic asset allocation index. Novavax Inc (NVAX) has a Strategic Asset Allocation Index of 378.4% as of March 2022. Strategic assets (PP&E of $247.21 Million plus long-term investments of $-) total $247.21 Million, measured against net assets of $65.32 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Novavax Inc balance sheet independence to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Novavax Inc (2000–2020)
Strategic asset allocation index of Novavax Inc from 2000 to 2020. This chart shows how Novavax Inc's Strategic Asset Allocation Index has evolved across 17 annual periods from 2000 to 2020. As of March 2022, the index stands at 378.4%, representing strategic assets of $247.21 Million against net assets of $65.32 Million USD. Check NVAX intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Novavax Inc Strategic Asset Allocation Index by Year (2000–2020)
Novavax Inc strategic asset allocation index by year from 2000 to 2020. The table below presents the year-by-year Strategic Asset Allocation Index for Novavax Inc from 2000 to 2020, covering 17 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Novavax Inc (NVAX) market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2020 | 28.7% | $179.95 Million | $179.95 Million | $- | $627.21 Million | ▲ +17.6 pp |
| 2015 | 11.1% | $32.34 Million | $32.34 Million | $- | $292.67 Million | ▲ +2.5 pp |
| 2014 | 8.6% | $19.74 Million | $19.74 Million | $- | $229.62 Million | ▲ +1.6 pp |
| 2013 | 7.0% | $14.25 Million | $14.25 Million | $- | $203.23 Million | ▼ -7.3 pp |
| 2012 | 14.3% | $11.46 Million | $11.46 Million | $- | $80.24 Million | ▲ +1.5 pp |
| 2011 | 12.7% | $6.86 Million | $6.86 Million | $- | $53.85 Million | ▼ -1.2 pp |
| 2010 | 13.9% | $8.21 Million | $8.21 Million | $- | $59.05 Million | ▲ +3.4 pp |
| 2009 | 10.5% | $7.80 Million | $7.80 Million | $- | $74.47 Million | ▼ -7.6 pp |
| 2008 | 18.1% | $8.23 Million | $8.23 Million | $- | $45.49 Million | ▲ +9.0 pp |
| 2007 | 9.1% | $5.72 Million | $5.72 Million | $- | $63.06 Million | ▼ -1.4 pp |
| 2006 | 10.5% | $9.86 Million | $9.86 Million | $- | $94.00 Million | ▼ -12.9 pp |
| 2005 | 23.3% | $11.59 Million | $11.59 Million | $- | $49.65 Million | ▼ -19.2 pp |
| 2004 | 42.5% | $14.15 Million | $14.15 Million | $- | $33.28 Million | ▲ +0.1 pp |
| 2003 | 42.4% | $15.24 Million | $15.24 Million | $- | $35.94 Million | ▼ -126.7 pp |
| 2002 | 169.1% | $13.65 Million | $13.65 Million | $- | $8.07 Million | ▲ +153.4 pp |
| 2001 | 15.7% | $4.33 Million | $4.33 Million | $- | $27.49 Million | ▲ +9.7 pp |
| 2000 | 6.1% | $1.93 Million | $1.93 Million | $- | $31.82 Million | — |